Home Journals Articles Updates About
CN
image
收藏切换
Bioengineered skin organoids: from development to applications
收藏切换
PDF
Zi-Xuan Hong1, †, Shun-Tian Zhu1, †, Hao Li1, †, Jing-Zhi Luo1, Yu Yang2, Yang An3, *, Xi Wang4, *, Kai Wang1, 4, 5, 6, *
Military Medical Research | 2024, 11(3) : 449 - 466
Less
收藏切换
Military Medical Research | 2024, 11(3): 449-466
• REVIEW •
Bioengineered skin organoids: from development to applications
Full
Zi-Xuan Hong1, †, Shun-Tian Zhu1, †, Hao Li1, †, Jing-Zhi Luo1, Yu Yang2, Yang An3, *, Xi Wang4, *, Kai Wang1, 4, 5, 6, *
Affiliations
  • 1Department of Physiology and Pathophysiology, School of Basic Medical Sciences, State Key Laboratory of Vascular Homeostasis and Remodeling, Peking University, Beijing 100191, China
  • 2Department of Hepatopancreatobiliary Surgery, the Third Affiliated Hospital of Soochow University, Changzhou 213000, Jiangsu, China
  • 3Department of Plastic Surgery, Peking University Third Hospital, Beijing 100191, China
  • 4Clinical Stem Cell Research Center, Peking University Third Hospital, Beijing 100191, China
  • 5State Key Laboratory of Cardiovascular Disease, Fuwai Hospital, Beijing 100037, China
  • 6Beijing Key Laboratory of Metabolic Disorder Related Cardiovascular Disease, Capital Medical University, Beijing 100050, China
Published: 2024-06-10 doi: 10.1186/s40779-023-00475-7
Outline
收藏切换

Signifcant advancements have been made in recent years in the development of highly sophisticated skin organoids. Serving as three-dimensional (3D) models that mimic human skin, these organoids have evolved into complex structures and are increasingly recognized as efective alternatives to traditional culture models and human skin due to their ability to overcome the limitations of two-dimensional (2D) systems and ethical concerns. The inherent plasticity of skin organoids allows for their construction into physiological and pathological models, enabling the study of skin development and dynamic changes. This review provides an overview of the pivotal work in the progression from 3D layered epidermis to cyst-like skin organoids with appendages. Furthermore, it highlights the latest advancements in organoid construction facilitated by state-of-the-art engineering techniques, such as 3D printing and microfuidic devices. The review also summarizes and discusses the diverse applications of skin organoids in developmental biology, disease modelling, regenerative medicine, and personalized medicine, while considering their prospects and limitations.

Skin organoid  /  Organoid generation  /  Skin appendage  /  Tissue engineering  /  Disease modelling  /  Regenerative medicine
Zi-Xuan Hong, Shun-Tian Zhu, Hao Li, Jing-Zhi Luo, Yu Yang, Yang An, Xi Wang, Kai Wang. Bioengineered skin organoids: from development to applications[J]. Military Medical Research, 2024 , 11 (3) : 449 -466 . DOI: 10.1186/s40779-023-00475-7
Full Text
Less
Background
Less
The skin, being the body's largest organ, performs a range of functions, including protection, sensation, and thermoregulation. It comprises three layers enclosed by a membrane: the epidermis, dermis, and hypodermis. The epidermis consists of closely interconnected keratinocytes that produce a stratum corneum to withstand environmental factors. The dermis is a complex structure, housing mechanoreceptors, sensory nerves, blood vessels, sweat glands, hair follicles, as well as an abundant extracellular matrix and fbroblasts. The hypodermis contains subcutaneous adipose tissue, which stores energy and growth factors[1,2]. The skin also houses a robust immune system, including Langerhans cells in the epidermis, dendritic cells in the dermis as part of the innate immune system, and peripheral leukocytes recruited during infection resistance[3].
The concept of organoids has evolved alongside advancements in related felds. Broadly speaking, organoids are three-dimensional (3D) cultures derived from pluripotent stem cells, fetal stem cells, or adult stem cells. In a broader sense, organoids refer to 3D cell cultures that can mimic specific features of organs or tissues in the human body. In our review, this broader definition encompasses the concepts of “cellular spheroid or aggregate”, “reconstructed 3D skin” and “bioengineered skin structure”. The skin organoids discussed in this review are in vitro 3D tissue constructs comprising various cell types and exhibiting morphological and functional competence as skin surrogates.
The idea of a skin culture system as an in vitro substitute was first proposed in 1975. Rheinwald et al.[4] were pioneers in developing a self-organizing strategy for generating squamous epithelium, which involved serial co-cultivation of primary human keratocytes and irradiated mouse fibroblasts. This breakthrough paved the way for in vitro culture of self-organized skin tissue. In 1989, a fibroblast feeding strategy was introduced to ensure stable settlement and expansion of keratinocytes[5]. Subsequently, embryonic stem cells (ESCs) and induced pluripotent stem cells (iPSCs) were successively utilized as powerful and efficient tools for studying in vitro skin organogenesis. In the late 2000s and early 2010s, 3D self-organized stratified epidermal equivalents derived from ESCs and iPSCs were developed, representing a significant milestone in the field of skin organoids[6-10]. This marked a major breakthrough, establishing skin organoids as potent tools for in vitro skin culture. In 2020, Lee et al.[11] reported the construction of an almost complete in vitro self-organized skin system differentiated from iPSCs, forming a hierarchical skin organoid that recapitulated many appendage structures, including hair follicles. Almost simultaneously, organoids containing sebaceous or sweat glands derived from reprogrammed epithelial tissue cells were developed, demonstrating the integration of appendages into a mature skin generation system[12,13] (Fig. 1a).
Skin organoids hold great promise for studying organogenesis, drug testing, and regenerative medicine. However, there are challenges related to scientific and ethical aspects that need to be addressed. These include the lack of key cell types and the inability to fully replicate the complex structure of native skin. Additionally, the long duration required for differentiation and maturation hinders their application in urgent patient needs. Furthermore, the limited size and lifespan of organoids restrict their broader application and accessibility. In this review, we aim to provide a comprehensive summary of existing studies on skin organoids, covering topics such as culture methods, maturation techniques, applications, and limitations. We believe that advancements in engineering methods and a deeper understanding of skin differentiation processes will accelerate the development of more robust and functional skin organoids[14].
Skin structure and organogenesis
Less
Epidermis
The epidermis, a stratified epithelium, consists of two main cell types: the basal layer containing epidermal stem cells and the superficial layer composed of specialized keratinocytes. The epidermal stem cells are responsible for the continuous regeneration of the epidermis, which occurs every 40–56 d, as they undergo proliferation[15]. As these proliferative cells move outward, they undergo differentiation, forming distinct layers in the epidermis, including the spinous, granular, and cornified layers[16]. Recent studies have revealed the presence of heterogeneous populations of epidermal stem cells, challenging the notion that a single population is solely responsible for maintaining the skin's plasticity and homeostasis[17].
During embryonic development, the epidermis originates from the surface ectoderm, which is characterized by the expression of Keratin 8 (KRT8) and KRT18 after neurulation. The Wnt signaling pathway plays a dominant role in directing the ectodermal cells towards an epidermal fate by inhibiting the response to fibroblast growth factors (FGFs). This inhibition promotes the expression of bone morphogenetic proteins (BMPs), which in turn initiate the differentiation process leading to epidermal formation[18]. As the cells in the basal layer of the epidermis, characteristic markers such as KRT5 and KRT14 are upregulated, while KRT8 and KRT18 are downregulated[19]. As keratinocyte progenitor cells commit to terminal differentiation, they migrate to the upper basal layer and express KRT10. Above this layer, the granular layer and cornified layer are formed and marked by the presence of filaggrin and loricrin[20]. The basement membrane provides structural support to the basal epidermal cells and also plays a crucial role in signaling pathways that determine cell fate and function[21]. Melanocytes, responsible for skin pigmentation, are located in the basal layer and originate from neural crest cells[22].
Dermis and hypodermis
The dermis, positioned beneath the epidermis's basement membrane, is a connective tissue layer that provides support to the epidermis and skin appendages. It is characterized by a rich extracellular matrix and contains blood vessels, lymphatics, nerves, adipocytes, and immune cells[23]. The dermis is divided into two distinct layers: the reticular dermis and the papillary dermis. The papillary dermis, with higher enzymatic activity and fibroblast density, plays a crucial role in hair follicle formation. On the other hand, the reticular dermis, located in the lower region, facilitates initial dermal repair and recruits cells from the former layer[24].
The dermis originates from three distinct mesenchymal sources. The neural crest contributes to the development of the dermis in the face and neck, while the lateral plate mesoderm is responsible for the dermis in the limbs and body wall. The paraxial mesoderm gives rise to the dermis in the back[2]. Fibroblasts throughout the dermis express high levels of platelet derived growth factor receptor α (PDGFRα) and PDGFRβ, which are involved in the regulation of collagen fibril assembly[25]. Interestingly, specific fibroblast markers can vary across species. In human skin, SFRP2/DPP4 and FMO1/LSP1 are used to define major fibroblast populations, while Watt's group has identified markers for murine dermal papilla (CRABP1), papillary (DPP4/CD26), and reticular (PDPN, SCA1/ATXN1) fibroblasts[24,26,27].
The hypodermis, situated beneath the reticular dermis, consists of loosely arranged connective tissue. The thickness of subcutaneous adipose tissue varies depending on body location, sex, and nutritional status. In addition to its role in thermal insulation and energy storage, adipocytes contribute to the regenerative cycle of hair follicles by secreting various factors, including platelet-derived growth factor (PDGF)[28,29].
Skin appendages
The skin appendages encompass the pilosebaceous unit, sweat glands, and nails. The pilosebaceous unit consists of the hair shaft, hair follicle, sebaceous gland, and arrector pili muscle. The hair shaft exhibits intricate structure and diverse patterns, distinguishing beard, hair, and lanugo from one another[30-32]. The development of the hair shaft involves multiple stem cell populations and signaling pathways. Ectodermal hair follicle stem cells (HFSCs) give rise to the sebaceous gland and apocrine gland, while mesoderm-derived cells develop into the follicular dermal papilla and the connective tissue sheath. Neural crest-derived melanocyte progenitors generate the pigmentary unit located near the dermal papilla[33]. The Wnt/β-catenin pathway plays a role in the activity and cell fate decisions of skin stem cells. Asymmetrical Wnt signaling leads to the formation of the hair medulla (marked by KRT75), inner root sheath (marked by KRT71), outer root sheath (marked by KRT5), and the bulge[34]. In the absence of β-catenin, the differentiation ends with the epidermis instead of follicular keratinocytes[35]. Paracrine transforming growth factor-β (TGF-β) activates SMAD2/3 to counterbalance the inhibitory signal of BMP. HFSCs express the target gene Tmeff1 to lower the BMP thresholds[36].
Mesenchymal-epithelial signaling regulates epidermal patterning and the morphogenesis of skin appendages[37]. Eccrine sweat glands express K7, K9, and carcinoembryonic antigen (CEA), with CEA being exclusively expressed in sweat glands found in normal skin[38]. Blimp1 plays a crucial role in the progenitor cells of sweat glands, and the loss of Blimp1 stimulates c-myc, which enhances bulge stem cell activity[39]. The specification of sweat glands occurs through mesenchymal-derived BMPs and fibroblast growth factors, which signal to epithelial buds and suppress epithelial-derived sonic hedgehog (SHH) production. Conversely, mesenchymal SHH outweighs BMP production in hair follicles, leading to their specification[40].
The specific identity of cells constituting the cutaneous niche responsible for skin homeostasis and regeneration remains poorly understood. Therefore, further research on the interaction and communication between different cell lineages is crucial for advancing the development of skin organoid models. Moreover, the skin exhibits variations throughout the body in terms of thickness, texture, and the presence of different structures. Certain areas of the skin, such as the palms and soles, have a thicker epidermis and lack the pilosebaceous unit, but host numerous sweat glands[2]. Therefore, the ability of skin organoids to regenerate multiple skin types in vitro is essential to accommodate the diverse characteristics of skin in distinct regions.
Generation of skin organoid
Less
3D layered skin substitute
3D in vitro skin analogues have the capability to faithfully replicate the complete structure and cellular composition of native skin, including the epidermis, dermis, and skin appendages, surpassing the accuracy and fidelity of conventional 2D models[41,42] (Fig. 1b). In 2011, Itoh et al.[9] successfully generated 3D skin equivalents by seeding iPSC-derived keratinocytes onto a matrix scaffold containing normal human fibroblasts (Fig. 1c). The differentiation of iPSCs into keratinocytes was achieved using retinoic acid (RA) and BMP4. RA promoted epithelial differentiation, while BMP4 prevented neural differentiation[43]. The resulting organoids exhibited stratification of iPSC keratinocytes and closely resembled the complex layering of the native epidermis[44]. Subsequently, fibroblasts isolated from normal human tissue were replaced with iPSC-derived fibroblasts, leading to the generation of purely iPSC-derived organoids[10]. Oceguera-Yanez et al.[20] and Kim et al.[45,46] followed a similar approach in constructing skin organoids. They generated iPSC lines from HLA-homozygous cord blood mononuclear cells and peripheral blood mononuclear cells. Their method offered advantages in overcoming immune rejection and showed great potential for clinical use. Additionally, they introduced EGF during keratinocyte differentiation to stimulate proliferation and differentiation[47]. The team successfully transplanted their organoids into immunodeficient mice, effectively healing skin lesions.
Engineering techniques have proven effective in restoring the complex structure of human skin. Blackstone et al.[48] utilized 3D printing to recreate rete ridge-like structures, resulting in a significant improvement in basement membrane formation and promoting epidermal proliferation and differentiation. Melanocytes, responsible for skin photoprotection and thermoregulation, are typically located in the basal layer of the epidermis at the junction with the dermis[49]. The addition of iPSC-derived melanocytes to skin equivalents has increased the complexity of in vitro skin models[50]. Supp et al.[51] demonstrated that such skin models possess photoprotective abilities, reducing the damage caused by UV-induced DNA damage.
Hair follicle organoid
The functionality and clinical applications of skin organoids have been significantly limited by the absence of skin appendages. Therefore, the regeneration of engineered skin tissue containing appendages is crucial for the development of human skin substitutes and advancements in regenerative medicine. One common approach to achieving in vitro human hair follicle formation involves combining dermal papilla cells with epithelial components. Isolated human dermal papilla cells can partially regain their inductive capability when grown as spheroids, leading to the induction of human hair follicle neogenesis[52]. Kalabusheva et al.[53] established two hair follicle germ models using human dermal papilla cells and keratinocytes. They found that the mixing of these two cell types as aggregates better represents the interactions between cells and their surrounding niche during hair follicle reconstruction compared to simply coating dermal papilla cells with keratinocytes. The researchers investigated the effects of various soluble factors and extracellular matrix components on the organoids and identified hyaluronic acid (HA) as a stimulating factor that significantly increased proliferation and aggregate size. In a similar study, the addition of hair follicle stem cells and silk fibroin to the culture system created a more complex microenvironment[54]. The organoids exhibited reduced levels of BMP signals and upregulated expression of the β-catenin gene, which are crucial for dermal papilla cell function, hair follicle differentiation, and hair cycle maintenance[35,55]. The model also demonstrated gene expression patterns similar to those observed in vivo, indicating its resemblance to the early-stage anagen phase of hair follicle development. Both of these studies constructed cell aggregates in vitro without transplanting them into animal models to validate their functionality. Su et al.[56] created a hair follicle organoid by mixing human dermal progenitor cells with epidermal stem cells and transplanted the aggregate onto the dorsal skin of nude mice, resulting in hair formation. Their research demonstrated the potential of hair follicle organoids to generate hair in vivo as grafts. They also identified Wnt pathway activation as indispensable for hair regeneration, with LEF1 serving as a biomarker for hair regeneration due to its significant expression during the formation of hair follicle organoids. However, the use of cells derived from fetal tissues may raise ethical concerns, necessitating the substitution of non-fetal cells such as human induced pluripotent stem cells (hiPSCs).
In 2020, Lee et al.[11] achieved a significant breakthrough in hair regrowth by creating a sophisticated human skin organoid from human pluripotent stem cells (Fig. 1e). They manipulated the TGF-β, FGF, and BMP signaling pathways and co-induced surface ectoderm cells and cranial neural crest cells within PSC aggregates. After approximately 140 d of incubation under floating rotation cultural conditions, the skin organoid developed into a complex tissue consisting of stratified epidermis, pigmented hair follicles, sebaceous glands, adipocytes, Merkel cells, and sensory neurons, closely resembling the natural process of skin development in vivo[57]. The hair follicles grew radially inward in vitro and assumed their normal morphology when the cell cysts unfolded into a planar skin structure after transplantation onto nude mice. The establishment of hair-bearing skin organoids with innervation provides an ideal model for studying skin neogenesis, structure, and diseases. Several studies have validated the feasibility of using and optimizing Lee's protocol to generate skin organoids from different hiPSC lines[58,59]. However, the long incubation period of over 140 d for in vitro skin organoids is labor-intensive and time-consuming, limiting its practical applications. In contrast, biofabrication methods offer an attractive approach to producing large quantities of skin appendage organoids. A recent study presented a culture system for generating human dermal papilla spheroids[60]. The researchers mixed human dermal papilla cell aggregates with Matrigel and co-cultured them with hair matrix cells and dermal sheath cup cells. However, a significant limitation was the use of cell lineages isolated from human tissues, making it challenging to generate ample amounts of skin substitutes. Therefore, future investigations are expected to focus on utilizing hiPSC-derived cells to construct hair follicle organoids.
Sweat gland organoid
Sweat glands originate from epidermal stem cells during embryonic development and consist of a duct segment and a secretory segment, surrounded by myoepithelial cells that aid in sweat secretion[61,62]. Reprogramming epidermal cells into sweat gland-like cells has been demonstrated in mice[63]. Sun et al.[64] successfully converted human epidermal keratinocytes into sweat gland cells by overexpressing EDA and stimulating β2-adrenoceptors, leading to the establishment of human sweat gland organoids from the reprogrammed cells. These organoids were then transplanted onto mice, resulting in the generation of functional sweat glands in vivo. In another study, Yao et al.[65] utilized 3D bioprinting techniques to guide the differentiation of mesenchymal stem cells into mouse sweat glands and demonstrated the ability to repair damaged sweat glands in vivo after transplantation. Their research also identified the crucial roles of Hmox1 and CTHRC1 in sweat gland differentiation.
Sebaceous gland organoid
Sebaceous glands are a vital component of the pilosebaceous unit and originate from a single progenitor cell cluster[66]. Mouse sebaceous gland organoids have been successfully generated using Blimp1+ cells isolated from adult mice[12] (Fig. 1d). In a complex skin organoid that mimics early organogenesis, sebaceous glands were observed after approximately 140 d of incubation, along with the presence of hair follicles[11]. However, the generation of human sebaceous gland organoids alone remains limited. One approach involves the use of immortalized cell lineages. Oulès et al.[67] successfully generated sebaceous gland organoids using SebE6E7 sebocytes, and these organoids displayed a glandular portion coated by the ductal portion. They also investigated the role of GATA6 in the organoid model, concluding that GATA6 is crucial in sebaceous differentiation and proliferation by regulating the TGF-β signaling pathway. While the cultivation of isolated sebaceous glands can contribute to the understanding of acne and other sebaceous gland-associated skin disorders[32], further research should aim to develop more complex structures that include other components of the pilosebaceous unit, such as hair follicles or even innervation[68].
Skin tumor organoid
Skin cancer is a prevalent form of cancer worldwide, and gaining insight into its development is essential for the development of prevention and treatment strategies. The three major types of skin cancer are basal cell carcinoma, squamous cell carcinoma, and melanoma, while merkel cell carcinoma, sebaceous carcinoma, and melanoma are less common.
Cutaneous squamous cell carcinoma originates from the cells that make up the epidermis, making it feasible to replace normal keratinocytes with cancer cells when generating skin substitutes. Berning et al.[69] created a dermal equivalent based on fibroblast-derived matrix to support the growth of normal epidermis and seeded various types of cutaneous squamous cell carcinoma-derived cells onto it to establish a 3D tumor organoid. This model successfully replicated the invasive phenotype and matrix metalloproteinase secretion observed in tumor tissue in vivo. The tumor microenvironment plays a crucial role in tumorigenesis and tumor maintenance, necessitating an appropriate in vitro tumor model with complex tumor-matrix interactions. To preserve the heterogeneity of tumor cells and the microenvironment, Engelmann and co-workers placed fresh cutaneous squamous cell carcinoma tissue slices, approximately 3 mm thick, on top of the dermal equivalent and cultured them for up to 21 d[70]. As a result, this model maintained the heterogeneity of tumor cells and the microenvironment, including vital immune cells. This promising tool provides an opportunity to investigate the response of tumor tissue to treatments such as irradiation and targeted therapies. A 3D bioprinted model of cutaneous squamous cell carcinoma was fabricated using a skin substitute consisting of a 3D-printed fibroblast-embedded collagen-based dermis, a basement membrane layer, and an epidermal layer of normal keratinocytes[71,72]. Although this model exhibited similar pathology, gene expression, and response to 5-fluorouracil treatment compared to tumor tissue in vivo, the manual pipetting of tumor cells onto the skin components impaired its consistency. To generate melanoma organoids, fresh tumor tissue obtained from patients was mechanically minced and enzymatically digested. The resulting spherical particles, ranging in size from 40 mm to 100 mm, were filtered and then resuspended in a solution of type Ⅰ rat tail collagen[73]. These tumor organoids contained autologous lymphoid and myeloid cell populations and exhibited responsiveness to immune checkpoint blockade in short-term 3D microfluidic culture. Furthermore, immune-enhanced tumor organoids were generated by adding patient-derived lymph node cells[74]. To better preserve the histologic growth patterns and infiltrating immune cells in the organoids, a biopsy strategy based on fine-needle aspiration (FNA) was employed, which demonstrated superior results compared to traditional methods[75].
Forsythe et al.[76] successfully established patient-specific organoids for Merkel cell carcinoma by resuspending tissue specimens in a hydrogel and photocrosslinking them under ultraviolet light exposure. They also created immune-enhanced organoids by incorporating immunocompetent cells, including CD8+ cells, CD4+ cells, and antigen-presenting cells (APCs), obtained from matched patient whole blood or nodal lymph tissue. This 10-day culture strategy demonstrated both chemosensitivity and immunosensitivity, showcasing its potential to evaluate different treatment regimens and provide valuable insights for clinicians.
Vascularized skin organoid
As organoids grow to a certain size, central necrosis becomes inevitable, particularly in parenchymal organ models like brain and liver organoids. This is due to the lack of an efficient vascular system for substance exchange. To replicate the in vivo structure of organs, it is crucial to recreate the interactions between the parenchyma and blood vessels. Therefore, vascularization is essential for long-term culture and the application of skin organoids in wound healing[76-78].
Vasculogenesis involves the self-assembly of vascular cells to form new blood vessels. Co-culturing with vascular cells has proven to be a reliable method for introducing blood vessels in various organoids, including liver organoids[79]. In Abaci's study, an increase in hair follicle density resulted in significant necrosis and inhibited hair growth. To improve the dermis-like structure, human umbilical vein endothelial cells (HUVECs) were added to the type Ⅰ collagen gel along with dermal fibroblasts at a ratio of 16:1. This resulted in the formation of capillary-like structures that became more organized and elongated after transplantation into mice[80]. Ebner-Peking et al.[81] generated spheroids consisting of endothelial colony-forming cells (ECFCs), fibroblasts, and keratinocytes derived from hiPSCs. Co-transplantation of endothelial progenitor cells accelerated vascularization and wound healing.
Growth factors such as FGF2 can facilitate angiogenesis. Xiong et al.[82] cultured 3D-printed skin organoids with scaffolds containing FGF2 and demonstrated that it promoted vascularization by recruiting endogenous cells after transplantation. VEGF, EGF, and PDGF are also incorporated into culture strategies due to their crucial effects on the natural wound healing process, although it remains to be seen whether they contribute to skin organoid angiogenesis[83]. In a recent study, attempts were made to introduce blood vessels into hiPSC-derived skin organoids using a self-assembly method[81]. The researchers transfected stabilized KGF mRNA and FGF-7 mRNA into hiPSCs to enhance keratinocyte differentiation and fitness, and used PDGFs in human platelet lysate to improve organoid proliferation and graft angiogenesis.
Microfluidic systems have been employed to simulate blood vessels and enhance vessel formation and perfusion in various types of organoids, including kidney and skin[84-86] (Fig. 2a). Mori et al.[87] fabricated perfusable vascular channels coated with endothelial cells within a cultured skin-equivalent. These artificial vessels can serve as pathways for delivering nutrients or as models for fabricated vascular networks. Skin organoids on a chip have also contributed to enhanced barrier properties and improved phenotypic differentiation. However, microfluidic devices have not yet been able to fully replicate capillaries in organoids[88].
Bioengineering strategies
Less
The limited reproducibility of the organoid model is a challenging aspect that can be addressed by implementing a controlled environment. In order to gain better control over the organization and functionality of stem cell-derived organoids, researchers have turned to bioengineering solutions. These solutions show great potential in enhancing maturation and reducing the need for xenogeneic materials[89]. Among these approaches, biomaterials-enhanced 3D bioprinting methods offer the ability to achieve more precise architectures and improve cellular placement compared to traditional models. Moreover, they provide a high-throughput and reproducible platform for drug screening and toxicity testing (Fig. 2b).
Hydrogel
Matrigel, derived from the secretions of Engelbreth-Holm-Swarm mouse sarcoma cells, is commonly used as a culture environment for organoids and has been shown to promote the maturation of skin appendages, including hair follicles and sweat glands[90,91]. However, the biochemical properties of different batches of Matrigel can vary, leading to poor reproducibility. To overcome this challenge, researchers have been exploring well-defined alternatives to this complex material, such as natural or synthetic hydrogels[92,93]. Collagen gels, which mimic the natural environment for fibroblasts, have been found to induce differentiation in various types of organoids and may be suitable for dermis culture[94]. However, processed collagen has weak mechanical properties, making it inherently unstable[95]. Modified gelatin derivatives, such as gelatin methacryloyl (GelMA), have shown improved degradability and stability. Barros et al.[96] developed a 3D skin model using GelMA, incorporating multilayered keratinocytes, dermal fibroblasts, and endothelial cells. Tan et al.[97] discovered that GelMA reduced the exfoliative behavior of keratinocytes due to its high attachment properties. Moreover, glycosaminoglycans (GAGs), fibrin, and other hydrogels have been integrated into skin equivalents due to their beneficial biological properties.
Scaffolds
Scaffold design is based on a comprehensive understanding of the extracellular matrix (ECM), which plays a pivotal role in biological adhesion, receptor signaling, cell survival, and morphogenesis (Fig. 2b). Scaffolds hold immense potential in skin tissue engineering and the culture of skin organoids. The decellularization of whole organs has been successfully applied in the heart, liver, kidney, and lung. Decellularized ECM (dECM) provides an optimal non-immunogenic microenvironment with natural 3D structures and various adhesion components[98]. DECM scaffolds can repair and regenerate skin tissues by preserving physical signals that promote keratinocyte adhesion and the growth of angiogenic cells[99,100]. Groeber et al.[101] successfully generated a vascularized skin equivalent by seeding cells on a decellularized segment of porcine jejunum. Numerous studies have demonstrated the remarkable potential of DECM in rapidly recapitulating organ function.
Inert scaffolds offer unique advantages. Porous scaffolds can take various forms, including sponges, foams, meshes, and biodegradable fibers. The ideal porous scaffold possesses a specific pore size, high porosity, and an appropriate surface-to-volume ratio, enabling the diffusion of nutrients and drugs. Furthermore, it must be biocompatible, biodegradable, and non-toxic to cells and the body[102-104]. Roger et al.[105] created a dermal construct with human fibroblasts that secrete ECM proteins using an inert porous scaffold to avoid the use of animal-derived materials. Electrospinning is utilized to produce fibrous scaffolds, often coated with adhesive proteins. Electrospun poly L-lactic acid (PLLA) fiber is a commonly used scaffold in tissue engineering and the generation of skin organoids. Ravindran Girija et al.[106] biofunctionalized the PLLA scaffold with collagen to enhance cell interactions. Adhesion and migration of seeded keratinocytes and fibroblasts were observed after 10 d.
Bioprinting
3D printing technology enables the creation of solid architectures to precisely regulate the spatial arrangement of cells[107]. Abaci et al.[80] utilized 3D printing molds to cast type Ⅰ collagen gel with dermal fibroblasts, mimicking the dermis with follicles. Skin organoids were generated by seeding dermal papilla cells (DPCs) in microwell gels of varying densities. Keratinocytes were then added to fill the microwells and serve as the epidermal component. After three weeks of generation, they observed keratinocyte differentiation and the expression of hair lineage markers. In some constructs, hair fibers elongated and spontaneously rearranged their positions from a right angle to an obtuse angle.
There are three primary strategies for bioprinting: extrusion, inkjet, and laser-assisted printing[107]. Cubo et al.[108] utilized extrusion printing modules consisting of four tunnels to combine human plasma, human fibroblasts, calcium chloride, and human keratinocytes. The resulting equivalents were allowed to differentiate for 17 d both in vitro and in vivo, exhibiting a stratum corneum and basement membrane structure. This technique enables printing a high density of cells but is limited by shear stress. Laser-assisted bioprinting was also employed to create cellularized skin substitutes capable of recapitulating rete ridge-like structures, resulting in a significant improvement in basement membrane formation and promoting epidermal proliferation and differentiation[48,109].
Applications and prospects
Less
Organoids offer a robust platform that allows researchers to manipulate cell populations and cellular environments artificially, catering to the study of a diverse range of physiological and pathological contexts. This holds great potential for investigating skin developmental biology, pathology, and clinical applications[110,111].
These application areas highlight the versatility and potential of skin organoids in advancing research and clinical applications in the field of skin biology.
Developmental biology
Access to human fetal tissue for laboratory investigation is limited due to ethical and regulatory challenges, which has hindered our advanced understanding of human skin development. Currently, research heavily relies on rodent models that do not fully replicate the features of human embryogenesis, resulting in significant gaps in our knowledge about human skin development. However, skin organoids offer a valuable resource for studying skin organogenesis, providing ample materials to investigate early human skin development and overcome the limitations of current research methods (Fig. 3a).
A promising avenue for future research is to explore the influence of the microenvironment and cell-to-cell interactions on stem or progenitor cells during skin development, including the intricate process of skin appendage induction, such as hair follicle formation. This process involves various signaling pathways, including Wnt, FGF, and BMP, which govern the early differentiation of ectodermal and mesenchymal cell lineages[18]. While the role of developmental signaling cues has been extensively studied in mice, there is a paucity of research directly examining these cues in human skin development[18,40,112,113]. Additionally, investigating the mechanical cues and their interplay with chemical signaling in skin maturation could be pursued by incorporating muscle into the system[114]. Cell migration is also a critical aspect of skin development, and understanding the fate of different lineages, such as melanocytes derived from neural crest cells, and their interaction with the environment during embryonic migration is crucial[22]. Pigmented hair organoids containing melanocytes provide an excellent model for studying the migration and maturation of this lineage[11].
Replicating the specific characteristics of different regions of human skin in skin organoid cultures represents an exciting avenue for embryonic development research. The human body exhibits diverse skin types that are specialized to specific anatomical locations. For instance, the skin on the soles of the feet is thicker and contains numerous sweat glands, while the skin on the eyelids and lips is thinner and lacks skin appendages. This regional heterogeneity is closely tied to dermis and substratum development, and further investigation using organoid models is necessary to enhance our understanding of these processes[113].
Furthermore, conducting comparative studies between human organoids and animal models, as well as organoids derived from animal models, can offer valuable insights into the developmental similarities or differences between humans and other species. For instance, hair follicle organoids have been successfully created using both mouse and human-induced pluripotent stem cells[11,115]. Extensive research can be conducted to explore the developmental and pathological features of these two types of organoids, providing additional evidence to either support or challenge the conclusions drawn from studies utilizing rodent models.
Disease modeling
Organoids offer a versatile tool for investigating the structural and cellular changes in human skin under various conditions, such as exposure to genotoxic substances, invasion by pathogenic microorganisms, or rare gene mutations. This enables detailed studies on the effects of different interventions at a cellular level. Moreover, the use of patient-derived cells in skin organoids allows for personalized therapies and drug screening, making them highly valuable in clinical applications[116]. Looking ahead, the development of complex 3D constructs and personalized scaffolds tailored to individual patient wounds holds great potential for customized treatment regimens[117] (Fig. 3b).
Infectious diseases
The skin is susceptible to microbial infections as it acts as the primary barrier of the human immune system. hiPSC-derived organoids cultivated using the air-liquid interface (ALI) method serve as an effective model to mimic atopic dermatitis. By activating Wnt signaling, this culture method forms a stratified squamous epithelial structure similar to human skin and allows for the colonization and infection of Staphylococcus aureus, mimicking the conditions of atopic dermatitis. This model provides a direct link between atopic dermatitis and Staphylococcus aureus colonization and infection, making it valuable for evaluating the efficacy of novel therapies[118]. Additionally, hair-bearing skin organoids have been employed to study hair loss in COVID-19 patients. Research has shown that SARS-CoV-2 can infect KRT17+ hair follicles and directly affect both hair follicle and neuronal development in the skin, leading to impaired hair follicle and epidermal growth[58].
Inherited diseases
Although inherited skin diseases may be rare, their severity necessitates a comprehensive understanding of their underlying mechanisms and the development of effective treatments. In the case of psoriasis, research has validated the therapeutic effect of a GLUT inhibitor on human skin organoids, offering a potential new strategy for managing this condition[119]. A 3D culture system utilizing hiPSC-derived epithelial and mesenchymal (EM) organoids has been introduced for localized scleroderma (LoS) therapy. This approach has shown promising results in reducing skin fibrosis in scleroderma-affected skin[120]. For junctional epidermolysis bullosa (JEB), combined ex vivo cell and gene therapies have successfully regenerated autologous transgenic keratinocytes, resulting in a fully functional epidermis and providing a novel therapeutic avenue for this disease[121]. Patient-specific iPSC-derived skin organoids have proven to be an effective platform for high-throughput drug screening. In a study related to systemic sclerosis (SSc), screening with patient-derived organoids identified selective estrogen receptor modulator (SERM)-class drugs as potential candidates for treating SSc fibrosis[46].
Skin tumor
Organoids have been used to recapitulate several types of skin cancers, including squamous cell carcinoma, melanoma, and Merkel cell carcinoma, as described above, providing valuable insight for basic research and clinical care. These tumor models have been able to replicate invasion phenotypes and model the tumor microenvironment, advancing research into tumor induction and development[69,122]. As individual differences and tumor heterogeneity can impact patient-specific treatment responses, patient-derived organoids have potential for personalized therapy. They can be used to monitor patient immune responses, tumor viability, and drug sensitivity, helping physicians determine the best quality regimen, particularly for refractory tumors.
Environmental exposure
Skin organoids offer a valuable platform for investigating the previously unknown effects of environmental factors on the skin. Researchers have utilized 3D skin organoids derived from hiPSC-derived keratinocytes to study the impact of ionizing radiation (IR) exposure and DNA damage response[44]. The findings revealed a decrease in DNA damage response, including DNA repair activity, during differentiation. In another study, low-dose γ-irradiation was applied to skin substitutes prior to transplantation onto nude mice, resulting in focal dysplasia in xenografted epidermises and exhibiting characteristics of epithelial-to-mesenchymal transition (EMT). This study highlighted that even minimal radiation stress during the regeneration of keratinocyte stem and precursor cells can create a microenvironment that may promote long-term carcinogenesis[42]. Additionally, investigating the effects of environmental factors, such as air pollution and cigarette smoking, on skin aging and related diseases is both feasible and necessary using in vitro treated skin organoids. The use of organoids provides a standardized tool for identifying related signaling pathways and gaining insights into the underlying mechanisms involved[123].
Regenerative medicine
Skin injuries resulting from surgery, trauma, or burns can have significant physiological and psychological impacts. Skin organoids offer a promising avenue for gaining deeper insights into the pathophysiology of challenging-to-heal wounds and the permanent loss of skin appendages. Moreover, they hold potential as a cell source for cell therapies and skin transplantation, making them viable candidates for autografting procedures and epithelial reconstitution surgeries[124] (Fig. 3c).
Conventional facial skin transplantation often involves harvesting tissue from other body parts, which can lead to scarring and immune rejection due to differences in function and composition compared to facial tissue[125]. In recent years, the use of skin organoids derived from hiPSCs for facial repair and skin reconstruction has been proposed, and significant progress has been made in producing skin organoids that can seamlessly integrate with mouse skin[81]. This approach effectively reduces scar formation and mitigates the issue of immune rejection, providing a valuable tool in the field of regenerative medicine[81,126]. In 2023, Pappalardo et al.[127] reported a groundbreaking study on the creation of wearable edgeless skin constructs using 3D printing, which minimizes the need for suturing and improves the effective coverage of wounds.
Skin wounds are highly sensitive to even minor temporal changes in various cytokines and non-coding RNAs, which can have a significant impact on wound healing[41,117]. Skin organoids have provided valuable in vitro models for studying wound healing, allowing researchers to investigate biophysical and biochemical cues without the need for costly and time-consuming animal studies. These mechanistic studies offer advantages that will greatly contribute to the clinical translation of organoids[128]. Importantly, these skin organoids are capable of releasing bioactive substances related to wound healing in a controlled manner and can recreate the intricate cell-cell and cell-extracellular matrix interactions of stem/progenitor cells. This capacity allows these 3D constructs to meet the necessary criteria for clinical applications[110].
Alopecia is a widespread condition that affects both males and females worldwide, significantly impacting their physical appearance. Fortunately, skin organoids present a promising solution for treating alopecia and restoring natural hair growth. The latest generation of hiPSC-derived organoids, which include hair follicles, can be developed for use in follicular unit transplantation[11]. This technique enables the production of new hair shafts that match the original donor site, avoiding potential harm associated with conventional hair transplantation in other areas of the scalp. Additionally, skin organoids can be genetically modified to enhance their survival and functionality in the recipient site, such as by reducing androgen receptors.
Limitations
Less
It is important to acknowledge the limitations of organoids, as they have hindered the development of their applications in disease modeling and clinical medicine. However, these challenges also provide valuable directions for further research.
While 3D organoids serve as useful in vitro skin models, they have certain limitations that restrict their utility in pathological studies of multiple organ systems. These limitations include a lack of normal inter-tissue communication, incomplete development of complex vasculature, and difficulties in establishing complex neural networks and immune cell clusters[20,129]. Moreover, skin organoids derived from hiPSCs only mimic early skin structures in the fetus and more mature structures after prolonged culture. They are not effective at modeling the intricate and dynamic changes that occur during aging and in vitro rejuvenation of senescent skin. These limitations highlight the heavy reliance of current skin organoid cultures on artificial nutritional and signaling support, underscoring their incomplete maturation[14].
Future studies can address these limitations by integrating microfluidic devices to mimic in vivo signaling centers and concentration gradients. This approach would enable better in vitro guidance and spatiotemporal control of skin organoid growth and self-organization, ultimately advancing organotypic cultures to the level of in vitro organ-on-a-chip systems. Additionally, in vivo transplantation of skin organoids into murine hosts can further promote their maturation[14,41,110,117,129,130]. Integration with multi-organ chips can also be explored to establish connections and communication between skin organoids and other preformed organoids[14,84,86]. Another approach to enhance the size and complexity of skin organoids is to incorporate angiogenesis-associated endothelial cells, peripheral nervous tissue stem cells, hematopoietic stem cells, and their corresponding microenvironments in co-culture systems. This would further establish the complex vasculature and neural networks within the organoids[41,110,129].
It is worth noting that there is currently no standardized protocol for constructing skin organoids worldwide[111]. Organoids relying on self-organizing principles often exhibit high heterogeneity, which presents a challenge in establishing standardized building materials and ensuring precise quality control and co-culture of cells. To address these challenges, the research strategy described above offers a potential solution by exploring stepwise procedures for skin organoid establishment and creating organoid biobanks for different pathologies[14].
A significant focus of current studies is to address the issue of immune rejection associated with organ transplantation, particularly in the context of hiPSC-derived organoids[81]. Immune rejection has limited the clinical application of skin transplantation[131]. Conventional strategies for large organ transplantation involve lifelong immunosuppressant treatment, which compromises the immune system and increases the risk of microbial infection and tumorigenesis. As a result, progress in this area has been slow and cautious[132]. However, hiPSC-derived skin organoids have the potential to overcome the problem of immune rejection, as they are theoretically non-immunogenic and suitable for largescale autografts[129]. Future studies must carefully evaluate the safety and efficacy of autologous stem cell transplantation of skin organoids to address the immune rejection issue[81]. This will ensure that the advantages of hiPSC-derived organoids are fully utilized while effectively addressing immune rejection associated with organ transplantation. The skin contains various immune cells, including Langerhans cells, dermal dendritic cells, and macrophages, which not only play a crucial role in combating infectious diseases but also contribute to the normal homeostasis of the skin. Therefore, incorporating immune components into skin organoid models significantly enhances their reliability and credibility. Previous studies have utilized hiPSC-derived skin organoids to model viral and bacterial infections[58,118]. While these investigations successfully replicate the physical barrier function of the skin, the absence of essential immune components may compromise the relevance of these models. It is therefore crucial to include immune components in skin organoid model systems. For example, autoimmune skin disorders such as psoriasis involve intricate interactions between immune cells and non-immune cells, with unclear underlying mechanisms[133]. Consequently, an ideal organoid platform that includes immune components has the potential to accelerate advancements in uncovering the underlying mechanisms and developing novel therapeutics. In the context of skin tumor organoids, co-culturing patient-derived immune cells with the tumor organoid has been employed[74,76]. This approach creates a more authentic model that faithfully mimics the interaction between tumor cells and the immune system. Overall, these co-culture strategies provide reliable protocols for the long-term maintenance of immune cells within skin organoid systems, facilitating groundbreaking studies of skin diseases[134].
The realization of personalized therapy necessitates the establishment of a population-based large-scale stem cell organoid bank for emergency management of severe burns. However, the personalized construction of organoids is currently limited by the high manufacturing costs, which hinders their applicability in precision therapy and makes it challenging to implement them in less-developed regions[135]. These challenges stem from inadequate expansion rates of stem cell populations, complex processes of directed differentiation into skin tissue, and substantial artificial intervention in terms of trophic and signaling support to the system[136]. To overcome these challenges, future strategies could involve the development of a new generation of standardized high-throughput construction techniques that reduce the costs of large-scale production, thereby making skin organoids more accessible for research and clinical applications[14,41].
Conclusions
Less
Skin organoids are emerging as a promising modelling strategy that drives advancements in healthcare, particularly in the fields of disease modelling and regenerative medicine. With continuous technical improvements, the culture system of skin organoids has matured, allowing them to progress from simple in vitro cultures to complex systems that encompass the epidermis, dermis, and appendages. The development of numerous skin organoids with diverse appendages and distinct phenotypes has provided a convenient and high-quality platform for studying skin development, microbial infections, inherited skin diseases, and neoplasms. These advantages not only lay a solid foundation for the clinical application of skin organoids in regenerative medicine and drug screening but also create opportunities for precision medicine and personalized treatment strategies. Although challenges persist, given the rapid technological advancements in the field, we are confident that skin organoid systems will continue to overcome their limitations and offer unprecedented opportunities to enhance human skin health.
Abbreviations
Less
2D/3D: Two dimensional/three dimensional; AD: Human atopic dermatitis; ALI: Air liquid interface; APC: Antigen presenting cell; Blimp1: B lymphocyte induced maturation protein 1; BMPs: Bone morphogenetic proteins; CEA: Carcinoembryonic antigen; CNCC: Cranial neural crest cell; CTHRC1: Collagen triple helix repeat containing 1; DECM: Decellularized extracellular matrix; DPCs: Dermal papilla cells; DPP4/CD26: Dipeptidyl peptidase4; ECFCs: Endothelial colony-forming cells; ECM: Extracellular matrix; EDA: Ectodysplasin A; EGF: Epidermal growth factor; EM: Epithelial and mesenchymal; EMT: Epithelial-to-mesenchymal transition; ESCs: Embryonic stem cells; FGFs: Fibroblast growth factors; FLG: Filaggrin; FMO1: Flavin-containing monooxygenase 1; FNA: Fine-needle aspiration; GAGs: Glycosaminoglycans; GelMA: Gelatin methacryloyl; GLUT: Glucose transporter; HA: Hyaluronic acid; HF: Hair follicle; HFSCs: Hair follicle stem cells; HLA: Human leukocyte antigen; Hmox1: Heme oxygenase 1; hTERT: Human telomerase reverse transcriptase; HUVECs: Human umbilical vein endothelial cells; iPSCs: Induced pluripotent stem cells; JEB: Junctional epidermolysis bullosa; KRT: Keratin; KGF: Keratinocyte growth factor; LEF1: Lymphoid enhancer-binding factor 1; LSP1: Lymphocyte specific protein 1; OMM: Organoid mature medium; PDGF: Platelet derived growth factor; PDGFR: Platelet derived growth actor receptor; PLLA: Poly L-lactic acid; RA: Retinoic acid; SebE6E7: Cell line name; SERM: Selective estrogen receptor modulator; SFRP2: Secreted frizzled-related protein 2; SHH: Sonic hedgehog; SMAD: Drosophila mothers against decapentaplegic protein; SSc: Systemic sclerosis; TGF-β: Transforming growth factor β; TP63: Tumor protein p63;
Acknowledgements
Less
Figures were created with BioRender.com.
Authors' contributions
Less
ZXH, STZ and HL contributed equally to this work. ZXH, STZ, HL and JZL wrote the manuscript. ZXH contributed to figure design. YY, YA, XW and KW revised and edited the manuscript. All authors read and approved the final manuscript.
Availability of data and materials
Less
Not applicable.
Declarations
Less
Ethics approval and consent to participate
Not applicable.
Consent for publication
Less
Not applicable.
Competing interests
Less
The authors declare that they have no competing interests.
Author details
Less
1Department of Physiology and Pathophysiology, School of Basic Medical Sciences, State Key Laboratory of Vascular Homeostasis and Remodeling, Peking University, Beijing 100191, China. 2Department of Hepatopancreatobiliary Surgery, the Third Affiliated Hospital of Soochow University, Changzhou 213000, Jiangsu, China. 3Department of Plastic Surgery, Peking University Third Hospital, Beijing 100191, China. 4Clinical Stem Cell Research Center, Peking University Third Hospital, Beijing 100191, China. 5State Key Laboratory of Cardiovascular Disease, Fuwai Hospital, Beijing 100037, China. 6Beijing Key Laboratory of Metabolic Disorder Related Cardiovascular Disease, Capital Medical University, Beijing 100050, China.
Funding
Less
  • National Key Research and Development Program of China(2022YFA1104800)
  • Beijing Nova Program(20220484100)
  • National Natural Science Foundation of China(81873939)
  • Open Research Fund of State Key Laboratory of Cardiovascular Disease, Fuwai Hospital(2022KF-04)
  • Clinical Medicine Plus X-Young Scholars Project, Peking University(PKU2022LCXQ003)
  • Emerging Engineering Interdisciplinary-Young Scholars Project, Peking University
  • Fundamental Research Funds for the Central Universities(PKU2023XGK011)
  • Open Research Fund of State Key Laboratory of Digital Medical Engineering, Southeast University(2023K-01)
  • Open Research Fund of Beijing Key Laboratory of Metabolic Disorder Related Cardiovascular Disease, Beijing, China(DXWL2023-01)
  • Science and Technology Bureau Foundation Application Project of Changzhou(CJ20220118)
References
Less
1.
Rodrigues M, Kosaric N, Bonham CA, Gurtner GC. Wound healing: a cellular perspective. Physiol Rev. 2019;99(1):665–706.
2.
Arda O, Göksügür N, Tüzün Y. Basic histological structure and functions of facial skin. Clin Dermatol. 2014;32(1):3–13.
3.
Kabashima K, Honda T, Ginhoux F, Egawa G. The immunological anatomy of the skin. Nat Rev Immunol. 2019;19(1):19–30.
4.
Rheinwatd JG, Green H. Seria cultivation of strains of human epidemal keratinocytes: the formation keratinizin colonies from single cell is. Cell. 1975;6(3):331–43.
5.
Limat A, Hunziker T, Boillat C, Bayreuther K, Noser F. Post-mitotic human dermal fibroblasts efficiently support the growth of human follicular keratinocytes. J Invest Dermatol. 1989;92(5):758–62.
6.
Thomson JA, Itskovitz-Eldor J, Shapiro SS, Waknitz MA, Swiergiel JJ, Marshall VS, et al. Embryonic stem cell lines derived from human blastocysts. Science. 1998;282(5391):1145–7.
7.
Takahashi K, Yamanaka S. Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors. Cell. 2006;126(4):663–76.
8.
Guenou H, Nissan X, Larcher F, Feteira J, Lemaitre G, Saidani M, et al. Human embryonic stem-cell derivatives for full reconstruction of the pluristratified epidermis: a preclinical study. Lancet. 2009;374(9703):1745–53.
9.
Itoh M, Kiuru M, Cairo MS, Christiano AM. Generation of keratinocytes from normal and recessive dystrophic epidermolysis bullosa-induced pluripotent stem cells. Proc Natl Acad Sci U S A. 2011;108(21):8797–802.
10.
Itoh M, Umegaki-Arao N, Guo Z, Liu L, Higgins CA, Christiano AM. Generation of 3D skin equivalents fully reconstituted from human induced pluripotent stem cells (iPSCs). PLoS One. 2013;8(10):e77673.
11.
Lee J, Rabbani CC, Gao H, Steinhart MR, Woodruff BM, Pflum ZE, et al. Hair-bearing human skin generated entirely from pluripotent stem cells. Nature. 2020;582(7812):399–404.
12.
Feldman A, Mukha D, Maor II, Sedov E, Koren E, Yosefzon Y, et al. Blimp1+ cells generate functional mouse sebaceous gland organoids in vitro. Nat Commun. 2019;10(1):2348.
13.
Diao J, Liu J, Wang S, Chang M, Wang X, Guo B, et al. Sweat gland organoids contribute to cutaneous wound healing and sweat gland regeneration. Cell Death Dis. 2019;10(3):238.
14.
Rossi G, Manfrin A, Lutolf MP. Progress and potential in organoid research. Nat Rev Genet. 2018;19(11):671–87.
15.
Koster MI. Making an epidermis. Ann N Y Acad Sci. 2009;1170:7-10.
16.
Morasso MI, Tomic-Canic M. Epidermal stem cells: the cradle of epidermal determination, differentiation and wound healing. Biol Cell. 2005;97(3):173–83.
17.
Fujiwara H, Tsutsui K, Morita R. Multi-tasking epidermal stem cells: beyond epidermal maintenance. Dev Growth Differ. 2018;60(9):531–41.
18.
Fuchs E. Scratching the surface of skin development. Nature. 2007;445(7130):834–42.
19.
Liu S, Zhang H, Duan E. Epidermal development in mammals: key regulators, signals from beneath, and stem cells. Int J Mol Sci. 2013;14(6):10869–95.
20.
Oceguera-Yanez F, Avila-Robinson A, Woltjen K. Differentiation of pluripotent stem cells for modeling human skin development and potential applications. Front Cell Dev Biol. 2022;10:1030339.
21.
Breitkreutz D, Koxholt I, Thiemann K, Nischt R. Skin basement membrane: the foundation of epidermal integrity—BM functions and diverse roles of bridging molecules nidogen and perlecan. Biomed Res Int. 2013;2013:179784.
22.
Mort RL, Jackson IJ, Patton EE. The melanocyte lineage in development and disease. Development. 2015;142(4):620–32.
23.
Woodley DT. Distinct fibroblasts in the papillary and reticular dermis implications for wound healing. Dermatol Clin. 2017;35(1):95–100.
24.
Driskell RR, Lichtenberger BM, Hoste E, Kretzschmar K, Simons BD, Charalambous M, et al. Distinct fibroblast lineages determine dermal architecture in skin development and repair. Nature. 2013;504(7479):277–81.
25.
Rippa AL, Kalabusheva EP, Vorotelyak EA. Regeneration of dermis: scarring and cells involved. Cells. 2019;8(6):607.
26.
Tabib T, Morse C, Wang T, Chen W, Lafyatis R. SFRP2/DPP4 and FMO1/LSP1 define major fibroblast populations in human skin. J Invest Dermatol. 2018;138(4):802–10.
27.
Philippeos C, Telerman SB, Oulès B, Pisco AO, Shaw TJ, Elgueta R, et al. Spatial and single-cell transcriptional profiling identifies functionally distinct human dermal fibroblast subpopulations. J Invest Dermatol. 2018;138(4):811–25.
28.
Festa E, Fretz J, Berry R, Schmidt B, Rodeheffer M, Horowitz M, et al. Adipocyte lineage cells contribute to the skin stem cell niche to drive hair cycling. Cell. 2011;146(5):761–71.
29.
Donati G, Proserpio V, Lichtenberger BM, Natsuga K, Sinclair R, Fujiwara H, et al. Epidermal Wnt/β-catenin signaling regulates adipocyte differentiation via secretion of adipogenic factors. Proc Natl Acad Sci U S A. 2014;111(15):E1501–9.
30.
Gu LH, Coulombe PA. Hedgehog signaling, keratin 6 induction, and sebaceous gland morphogenesis implications for pachyonychia congenita and related conditions. Am J Pathol. 2008;173(3):752–61.
31.
Langbein L, Yoshida H, Praetzel-Wunder S, Parry DA, Schweizer J. The keratins of the human beard hair medulla: the riddle in the middle. J Invest Dermatol. 2010;130(1):55–73.
32.
Zouboulis CC, Picardo M, Ju Q, Kurokawa I, Törőcsik D, Bíró T, et al. Beyond acne: current aspects of sebaceous gland biology and function. Rev Endocr Metab Disord. 2016;17(3):319–34.
33.
Schneider MR, Schmidt-Ullrich R, Paus R. The hair follicle as a dynamic miniorgan. Curr Biol. 2009;19(3):R132–42.
34.
Gonzales KAU, Fuchs E. Skin and its regenerative powers: an alliance between stem cells and their niche. Dev Cell. 2017;43(4):387–401.
35.
Huelsken J, Vogel R, Erdmann B, Cotsarelis G, Birchmeier W. Betacontrols hair follicle morphogenesis and stem cell differentiation in the skin. Cell. 2001;105(4):533–45.
36.
Oshimori N, Fuchs E. Paracrine TGF-β signaling counterbalances BMPmediated repression in hair follicle stem cell activation. Cell Stem Cell. 2012;10(1):63–75.
37.
Lim X, Nusse R. Wnt signaling in skin development, homeostasis, and disease. Cold Spring Harb Perspect Biol. 2013;5(2):a008029.
38.
Li H, Zhou G, Fu X, Zhang L. Antigen expression of human eccrine sweat glands. J Cutan Pathol. 2009;36(3):318–24.
39.
Horsley V, O'Carroll D, Tooze R, Ohinata Y, Saitou M, Obukhanych T, et al. Blimp1 defines a progenitor population that governs cellular input to the sebaceous gland. Cell. 2006;126(3):597–609.
40.
Lu CP, Polak L, Keyes BE, Fuchs E. Spatiotemporal antagonism in mesenchymal-epithelial signaling in sweat versus hair fate decision. Science. 2016;354(6319):aah6102.
41.
Hosseini M, Koehler KR, Shafiee A. Biofabrication of human skin with its appendages. Adv Healthc Mater. 2022;11(22):2201626.
42.
Cavallero S, Neves Granito R, Stockholm D, Azzolin P, Martin MT, Fortunel NO. Exposure of human skin organoids to low genotoxic stress can promote epithelial-to-mesenchymal transition in regenerating keratinocyte precursor cells. Cells. 2020;9(8):1912.
43.
Metallo CM, Ji L, de Pablo JJ, Palecek SP. Retinoic acid and bone morphogenetic protein signaling synergize to efficiently direct epithelial differentiation of human embryonic stem cells. Stem Cells. 2008;26(2):372–80.
44.
Miyake T, Shimada M, Matsumoto Y, Okino A. DNA damage response after ionizing radiation exposure in skin keratinocytes derived from human-induced pluripotent stem cells. Int J Radiat Oncol Biol Phys. 2019;105(1):193–205.
45.
Kim Y, Park N, Rim YA, Nam Y, Jung H, Lee K, et al. Establishment of a complex skin structure via layered co-culture of keratinocytes and fibroblasts derived from induced pluripotent stem cells. Stem Cell Res Ther. 2018;9(1):217.
46.
Kim Y, Nam Y, Rim YA, Ju JH. Anti-fibrotic effect of a selective estrogen receptor modulator in systemic sclerosis. Stem Cell Res Ther. 2022;13(1):303.
47.
Marchese C, Rubin J, Ron D, Faggioni A, Torrisi MR, Messina A, et al. Human keratinocyte growth factor activity on proliferation and differentiation of human keratinocytes: differentiation response distinguishes KGF from EGF family. J Cell Physiol. 1990;144(2):326–32.
48.
Blackstone BN, Malara MM, Baumann ME, McFarland KL, Supp DM, Powell HM. Fractional CO2 laser micropatterning of cell-seeded electrospun collagen scaffolds enables rete ridge formation in 3D engineered skin. Acta Biomater. 2020;102:287-97.
49.
Lin JY, Fisher DE. Melanocyte biology and skin pigmentation. Nature. 2007;445(7130):843–50.
50.
Gledhill K, Guo Z, Umegaki-Arao N, Higgins CA, Itoh M, Christiano AM. Melanin transfer in human 3D skin equivalents generated exclusively from induced pluripotent stem cells. PLoS One. 2015;10(8):e0136713.
51.
Supp DM, Hahn JM, Lloyd CM, Combs KA, Swope VB, Abdel-Malek Z, et al. Light or dark pigmentation of engineered skin substitutes containing melanocytes protects against ultraviolet light-induced DNA damage in vivo. J Burn Care Res. 2020;41(4):751–60.
52.
Higgins CA, Chen JC, Cerise JE, Jahoda CAB, Christiano AM. Microenvironmental reprogramming by three-dimensional culture enables dermal papilla cells to induce de novo human hair-follicle growth. Proc Natl Acad Sci U S A. 2013;110(49):19679–88.
53.
Kalabusheva E, Terskikh V, Vorotelyak E. Hair germ model in vitro via human postnatal keratinocyte-dermal papilla interactions: impact of hyaluronic acid. Stem Cells Int. 2017;2017:9271869.
54.
Gupta AC, Chawla S, Hegde A, Singh D, Bandyopadhyay B, Lakshmanan CC, et al. Establishment of an in vitro organoid model of dermal papilla of human hair follicle. J Cell Physiol. 2018;233(11):9015–30.
55.
Rendl M, Polak L, Fuchs E. BMP signaling in dermal papilla cells is required for their hair follicle-inductive properties. Genes Dev. 2008;22(4):543–57.
56.
Su Y, Wen J, Zhu J, Xie Z, Liu C, Ma C, et al. Pre-aggregation of scalp progenitor dermal and epidermal stem cells activates the WNT pathway and promotes hair follicle formation in in vitro and in vivo systems. Stem Cell Res Ther. 2019;10(1):403.
57.
Lee J, van der Valk WH, Serdy SA, Deakin C, Kim J, Le AP, et al. Generation and characterization of hair-bearing skin organoids from human pluripotent stem cells. Nat Protoc. 2022;17(5):1266–305.
58.
Ma J, Liu J, Gao D, Li X, Zhang Q, Lv L, et al. Establishment of human pluripotent stem cell-derived skin organoids enabled pathophysiological model of SARS-CoV-2 infection. Adv Sci (Weinh). 2022;9(7):e2104192.
59.
Ramovs V, Janssen H, Fuentes I, et al. Characterization of the epidermaldermal junction in hiPSC-derived skin organoids. Stem Cell Rep. 2022;17(6):1279–88.
60.
Liu Z, Huang J, Kang D, Zhou Y, Du L, Qu Q, et al. Microenvironmental reprogramming of human dermal papilla cells for hair follicle tissue engineering. Acta Biomater. 2023;165:31-49.
61.
Fu X, Li J, Sun X, Sun T, Sheng Z. Epidermal stem cells are the source of sweat glands in human fetal skin: evidence of synergetic development of stem cells, sweat glands, growth factors, and matrix metalloproteinases. Wound Repair Regen. 2005;13(1):102–8.
62.
Zhang C, Chen Y, Fu X. Sweat gland regeneration after burn injury: is stem cell therapy a new hope?. Cytotherapy. 2015;17(5):526–35.
63.
Yao B, Xie J, Liu N, Hu T, Song W, Huang S, et al. Direct reprogramming of epidermal cells toward sweat gland-like cells by defined factors. Cell Death Dis. 2019;10(4):272.
64.
Sun X, Xiang J, Chen R, Geng Z, Wang L, Liu Y, et al. Sweat gland organoids originating from reprogrammed epidermal keratinocytes functionally recapitulated damaged skin. Adv Sci (Weinh). 2021;8(22):e2103079.
65.
Yao B, Wang R, Wang Y, Zhang Y, Hu T, Song W, et al. Biochemical and structural cues of 3D-printed matrix synergistically direct MSC differentiation for functional sweat gland regeneration. Sci Adv. 2020;6(10):eaaz1094.
66.
Niemann C, Horsley V. Development and homeostasis of the sebaceous gland. Semin Cell Dev Biol. 2012;23(8):928–36.
67.
Oulès B, Philippeos C, Segal J, Tihy M, Rudan MV, Cujba AM, et al. Contribution of GATA6 to homeostasis of the human upper pilosebaceous unit and acne pathogenesis. Nat Commun. 2020;11(1):5067.
68.
Clayton RW, Langan EA, Ansell DM, Vos IJHM, Göbel K, Schneider MR, et al. Neuroendocrinology and neurobiology of sebaceous glands. Biol Rev Camb Philos Soc. 2020;95(3):592–624.
69.
Berning M, Prätzel-Wunder S, Bickenbach JR, Boukamp P. Three-dimensional in vitro skin and skin cancer models based on human fibroblastderived matrix. Tissue Eng Part C Methods. 2015;21(9):958–70.
70.
Engelmann L, Thierauf J, Koerich Laureano N, Stark HJ, Prigge ES, Horn D, et al. Organotypic co-cultures as a novel 3D model for head and neck squamous cell carcinoma. Cancers. 2020;12(8):2330.
71.
Derr K, Zou J, Luo K, Song MJ, Sittampalam GS, Zhou C, et al. Fully three-dimensional bioprinted skin equivalent constructs with validated morphology and barrier function. Tissue Eng Part C Methods. 2019;25(6):334–43.
72.
Browning JR, Derr P, Derr K, Doudican N, Michael S, Lish SR, et al. A 3D biofabricated cutaneous squamous cell carcinoma tissue model with multi-channel confocal microscopy imaging biomarkers to quantify antitumor effects of chemotherapeutics in tissue. Oncotarget. 2020;11(27):2587–96.
73.
Jenkins RW, Aref AR, Lizotte PH, Ivanova E, Stinson S, Zhou CW, et al. Ex vivo profiling of PD-1 blockade using organotypic tumor spheroids. Cancer Discov. 2018;8(2):196–215.
74.
Votanopoulos KI, Forsythe S, Sivakumar H, Mazzocchi A, Aleman J, Miller L, et al. Model of patient-specific immune-enhanced organoids for immunotherapy screening: feasibility study. Ann Surg Oncol. 2020;27(6):1956–67.
75.
Vilgelm AE, Bergdorf K, Wolf M, Bharti V, Shattuck-Brandt R, Blevins A, et al. Fine-needle aspiration-based patient-derived cancer organoids. iScience. 2020;23(8):101408.
76.
Forsythe SD, Erali RA, Laney P, Sivakumar H, Li W, Skardal A, et al. Application of immune enhanced organoids in modeling personalized Merkel cell carcinoma research. Sci Rep-UK. 2022;12(1):13865.
77.
Grebenyuk S, Ranga A. Engineering organoid vascularization. Front Bioeng Biotechnol. 2019;7:39.
78.
Ma X, Li H, Zhu S, Hong Z, Kong W, Yuan Q, et al. Angiorganoid: vitalizing the organoid with blood vessels. Vasc Biol. 2022;4(1):R44–57.
79.
Takebe T, Sekine K, Enomura M, Koike H, Kimura M, Ogaeri T, et al. Vascularized and functional human liver from an iPSC-derived organ bud transplant. Nature. 2013;499(7459):481.
80.
Abaci HE, Coffman A, Doucet Y, Chen J, Jacków J, Wang E, et al. Tissue engineering of human hair follicles using a biomimetic developmental approach. Nat Commun. 2018;9(1):5301.
81.
Ebner-Peking P, Krisch L, Wolf M, Hochmann S, Hoog A, Vári B, et al. Selfassembly of differentiated progenitor cells facilitates spheroid human skin organoid formation and planar skin regeneration. Theranostics. 2021;11(17):8430–47.
82.
Xiong S, Zhang X, Lu P, Wu Y, Wang Q, Sun H, et al. A gelatin-sulfonated silk composite scaffold based on 3D printing technology enhances skin regeneration by stimulating epidermal growth and dermal neovascularization. Sci Rep. 2017;7(1):4288.
83.
Park JW, Hwang SR, Yoon IS. Advanced growth factor delivery systems in wound management and skin regeneration. Molecules. 2017;22(8):1259.
84.
Ronaldson-Bouchard K, Teles D, Yeager K, Tavakol DN, Zhao Y, Chramiec A, et al. A multi-organ chip with matured tissue niches linked by vascular flow. Nat Biomed Eng. 2022;6(4):351–71.
85.
Homan KA, Gupta N, Kroll KT, Kolesky DB, Skylar-Scott M, Miyoshi T, et al. Flow-enhanced vascularization and maturation of kidney organoids in vitro. Nat Methods. 2019;1-8.
86.
Novak R, Ingram M, Marquez S, Das D, Delahanty A, Herland A, et al. Robotic fluidic coupling and interrogation of multiple vascularized organ chips. Nat Biomed Eng. 2020;4(4):407–20.
87.
Mori N, Morimoto Y, Takeuchi S. Skin integrated with perfusable vascular channels on a chip. Biomaterials. 2017;116:48-56.
88.
Sutterby E, Thurgood P, Baratchi S, Khoshmanesh K, Pirogova E. Microfluidic skin-on-a-chip models: toward biomimetic artificial skin. Small. 2020;16(39):e2002515.
89.
Garreta E, Kamm RD, Lopes SMCdS, Lancaster MA, Weiss R, Trepat X, et al. Rethinking organoid technology through bioengineering. Nat Mater. 2021;20(2):145–55.
90.
Hughes CS, Postovit LM, Lajoie GA. Matrigel: a complex protein mixture required for optimal growth of cell culture. Proteomics. 2010;10(9):1886–90.
91.
Li H, Chen L, Zhang M, Tang S, Fu X. Three-dimensional culture and identification of human eccrine sweat glands in matrigel basement membrane matrix. Cell Tissue Res. 2013;354(3):897–902.
92.
Kaur S, Kaur I, Rawal P, Tripathi DM, Vasudevan A. Non-matrigel scaffolds for organoid cultures. Cancer Lett. 2021;504:58-66.
93.
Kozlowski MT, Crook CJ, Ku HT. Towards organoid culture without matrigel. Commun Biol. 2021;4(1):1387.
94.
Dosh RH, Jordan-Mahy N, Sammon C, Maitre CLL. Use of l -pNIPAM hydrogel as a 3D-scaffold for intestinal crypts and stem cell tissue engineering. Biomater Sci. 2019;7(10):4310–24.
95.
Tan SH, Chua DAC, Tang JRJ, Bonnard C, Leavesley D, Liang K. Design of hydrogel-based scaffolds for in vitro three-dimensional human skin model reconstruction. Acta Biomater. 2022;153:13-37.
96.
Barros NR, Kim HJ, Gouidie MJ, Lee K, Bandaru P, Banton EA, et al. Biofabrication of endothelial cell, dermal fibroblast, and multilayered keratinocyte layers for skin tissue engineering. Biofabrication. 2021.
97.
Tan JJY, Nguyen DV, Common JE, Wu C, Ho PCL, Kang L. Investigating PEGDA and GelMA microgel models for sustained 3D heterotypic dermal papilla and keratinocyte co-cultures. Int J Mol Sci. 2021;22(4):2143.
98.
Zhang X, Chen X, Hong H, Hu R, Liu J, Liu C. Decellularized extracellular matrix scaffolds: recent trends and emerging strategies in tissue engineering. Bioact Mater. 2022;10:15-31.
99.
Choi JS, Kim JD, Yoon HS, Cho YW. Full-thickness skin wound healing using human placenta-derived extracellular matrix containing bioactive molecules. Tissue Eng Part A. 2013;19(3–4):329–39.
100.
Zhang Q, Johnson JA, Dunne LW, Chen Y, Iyyanki T, Wu Y, et al. Decellularized skin/adipose tissue flap matrix for engineering vascularized composite soft tissue flaps. Acta Biomater. 2016;35:166-84.
101.
Groeber F, Engelhardt L, Lange J, Kurdyn S, Schmid FF, Rücker C, et al. A first vascularized skin equivalent as an alternative to animal experimentation. Altex. 2016;33(4):415–22.
102.
Tarassoli SP, Jessop ZM, Al-Sabah A, Gao N, Whitaker S, Doak S, et al. Skin tissue engineering using 3D bioprinting: an evolving research field. J Plast Reconstr Aesthet Surg. 2018;71(5):615–23.
103.
Murphy SV, Skardal A, Atala A. Evaluation of hydrogels for bio-printing applications. J Biomed Mater Res A. 2013;101(1):272–84.
104.
Chaudhari AA, Vig K, Baganizi DR, Sahu R, Dixit S, Dennis V, et al. Future prospects for scaffolding methods and biomaterials in skin tissue engineering: a review. Int J Mol Sci. 2016;17(12):1974.
105.
Roger M, Fullard N, Costello L, Bradbury S, Markiewicz E, O'Reilly S, et al. Bioengineering the microanatomy of human skin. J Anat. 2019;234(4):438–55.
106.
Ravindran Girija A, Palaninathan V, Strudwick X, Balasubramanian S, Nair SD, Cowin AJ. Collagen-functionalized electrospun smooth and porous polymeric scaffolds for the development of human skin-equivalent. RSC Adv. 2020;10(45):26594–603.
107.
Murphy SV, Atala A. 3D bioprinting of tissues and organs. Nat Biotechnol. 2014;32(8):773–85.
108.
Cubo N, Garcia M, Del Cañizo JF, Velasco D, Jorcano JL. 3D bioprinting of functional human skin: production and in vivo analysis. Biofabrication. 2016;9(1):015006.
109.
Michael S, Sorg H, Peck CT, Koch L, Deiwick A, Chichkov B, et al. Tissue engineered skin substitutes created by laser-assisted bioprinting form skin-like structures in the dorsal skin fold chamber in mice. PLoS One. 2013;8(3):e57741.
110.
de Groot SC, Ulrich MMW, Gho CG, Huisman MA. Back to the future: from appendage development toward future human hair follicle neogenesis. Front Cell Dev Biol. 2021;9:661787.
111.
Kim J, Koo BK, Knoblich JA. Human organoids: model systems for human biology and medicine. Nat Rev Mol Cell Biol. 2020;21(10):571–84.
112.
Zhang Y, Tomann P, Andl T, Gallant NM, Huelsken J, Jerchow B, et al. Reciprocal requirements for EDA/EDAR/NF-kappaB and Wnt/β-catenin signaling pathways in hair follicle induction. Dev Cell. 2009;17(1):49–61.
113.
Zhu XJ, Liu Y, Dai ZM, Zhang X, Yang X, Li Y, et al. BMP-FGF signaling axis mediates Wnt-induced epidermal stratification in developing mammalian skin. PLoS Genet. 2014;10(10):e1004687.
114.
Le AP, Kim J, Koehler KR. The mechanical forces that shape our senses. Development. 2022;149(7):dev197947.
115.
Lee J, Bӧscke R, Tang PC, Hartman BH, Heller S, Koehler KR. Hair follicle development in mouse pluripotent stem cell-derived skin organoids. Cell Rep. 2018;22(1):242–54.
116.
Kim Y, Ju JH. Generation of 3D skin organoid from cord blood-derived induced pluripotent stem cells. J Vis Exp. 2019;146.
117.
Tan SH, Ngo ZH, Sci DB, Leavesley D, Liang K. Recent advances in the design of three-dimensional and bioprinted scaffolds for full-thickness wound healing. Tissue Eng Part B Rev. 2022;28(1):160–81.
118.
Jung SY, You HJ, Kim MJ, Ko G, Lee S, Kang KS. Wnt-activating human skin organoid model of atopic dermatitis induced by Staphylococcus aureus and its protective effects by Cutibacterium acnes. iScience. 2022;25(10):105150.
119.
Zhang Z, Zi Z, Lee EE, Zhao J, Contreras DC, South AP, et al. Differential glucose requirement in skin homeostasis and injury identifies a therapeutic target for psoriasis. Nat Med. 2018;24(5):617–27.
120.
Ma J, Li W, Cao R, Gao D, Zhang Q, Li X, et al. Application of an iPSC-derived organoid model for localized scleroderma therapy. Adv Sci (Weinh). 2022;9(16):e2106075.
121.
Hirsch T, Rothoeft T, Teig N, Bauer JW, Pellegrini G, Rosa LD, et al. Regeneration of the entire human epidermis using transgenic stem cells. Nature. 2017;551(7680):327–32.
122.
Neal JT, Li X, Zhu J, Giangarra V, Grzeskowiak CL, Ju J, et al. Organoid modeling of the tumor immune microenvironment. Cell. 2018;175(7):1972–1988.e16.
123.
Fussell JC, Kelly FJ. Oxidative contribution of air pollution to extrinsic skin ageing. Free Radic Biol Med. 2020;151:111-22.
124.
Yang R, Liu F, Wang J, Chen X, Xie J, Xiong K. Epidermal stem cells in wound healing and their clinical applications. Stem Cell Res Ther. 2019;10(1):229.
125.
Wu H, Wang G, Shang Y, Liu N, Zhen Y, Chen L, et al. Organoids and their research progress in plastic and reconstructive surgery. Aesth Plast Surg. 2023;47:880-91.
126.
Fu XB. Repair cell first, then regenerate the tissues and organs. Mil Med Res. 2021;8:2.
127.
Pappalardo A, Cespedes DA, Fang S, Herschman AR, Jeon EY, Myers KM, et al. Engineering edgeless human skin with enhanced biomechanical properties. Sci Adv. 2023;9(4):eade2514.
128.
Ntshingila S, Khumalo NP, Engel M, Arowolo AT. An appraisal of laboratory models of androgenetic alopecia: a systematic review. Ski Health Dis. 2021;1(2):e15.
129.
Dash BC, Korutla L, Vallabhajosyula P, Hsia HC. Unlocking the potential of induced pluripotent stem cells for wound healing: the next frontier of regenerative medicine. Adv Wound Care. 2022;11(11):622–38.
130.
Atwood SX, Plikus MV. Fostering a healthy culture: biological relevance of in vitro and ex vivo skin models. Exp Dermatol. 2021;30(3):298–303.
131.
Wang Y, Wang JY, Schnieke A, Fischer K. Advances in single-cell sequencing: insights from organ transplantation. Mil Med Res. 2021;8:45.
132.
Yamanaka S. Pluripotent stem cell-based cell therapy-promise and challenges. Cell Stem Cell. 2020;27(4):523–31.
133.
Ayala-Fontánez N, Soler DC, McCormick TS. Current knowledge on psoriasis and autoimmune diseases. Psoriasis (Auckl). 2016;6:7-32.
134.
Moon S, Kim DH, Shin JU. In vitro models mimicking immune response in the skin. Yonsei Med J. 2021;62(11):969–80.
135.
Sun H, Zhang YX, Li YM. Generation of skin organoids: potential opportunities and challenges. Front Cell Dev Biol. 2021;9:709824.
136.
Cohen PJR, Luquet E, Pletenka J, Leonard A, Warter E, Gurchenkov B, et al. Engineering 3D micro-compartments for highly efficient and scale-independent expansion of human pluripotent stem cells in bioreactors. Biomaterials. 2023;295:122033.
Appendix
Less
Year 2024 volume 11 Issue 3
PDF
70
39
Cite this Article
BibTeX
Article Info
doi: 10.1186/s40779-023-00475-7
  • Online Date：2025-11-20
  • Published：2024-06-10
Article Data
Affiliations
History
Funding
National Key Research and Development Program of China(2022YFA1104800)
Beijing Nova Program(20220484100)
National Natural Science Foundation of China(81873939)
Open Research Fund of State Key Laboratory of Cardiovascular Disease, Fuwai Hospital(2022KF-04)
Clinical Medicine Plus X-Young Scholars Project, Peking University(PKU2022LCXQ003)
Emerging Engineering Interdisciplinary-Young Scholars Project, Peking University
Fundamental Research Funds for the Central Universities(PKU2023XGK011)
Open Research Fund of State Key Laboratory of Digital Medical Engineering, Southeast University(2023K-01)
Open Research Fund of Beijing Key Laboratory of Metabolic Disorder Related Cardiovascular Disease, Beijing, China(DXWL2023-01)
Science and Technology Bureau Foundation Application Project of Changzhou(CJ20220118)
Affiliations
    1Department of Physiology and Pathophysiology, School of Basic Medical Sciences, State Key Laboratory of Vascular Homeostasis and Remodeling, Peking University, Beijing 100191, China
    2Department of Hepatopancreatobiliary Surgery, the Third Affiliated Hospital of Soochow University, Changzhou 213000, Jiangsu, China
    3Department of Plastic Surgery, Peking University Third Hospital, Beijing 100191, China
    4Clinical Stem Cell Research Center, Peking University Third Hospital, Beijing 100191, China
    5State Key Laboratory of Cardiovascular Disease, Fuwai Hospital, Beijing 100037, China
    6Beijing Key Laboratory of Metabolic Disorder Related Cardiovascular Disease, Capital Medical University, Beijing 100050, China

Corresponding:

References
Share
https://castjournals.cast.org.cn/joweb/mmr/EN/10.1186/s40779-023-00475-7
Share to
QR

Scan QR to access full text

Cite this article
BibTeX
Citations
表12种不同金属材料的力学参数
科
Family		 属数
Number of
genus		 种数
Number of
species		 占总种数比例
Percentage of
total species (%)		 属
Genus		 种数
Number of
species		 占总种数比例
Percentage of total
species (%)
鹅膏菌科Amanitaceae 2 11 5.26 鹅膏菌属 Amanita 10 4.78
小菇科 Mycenaceae 2 12 5.74 丝盖伞属 Inocybe 5 2.39
多孔菌科 Polyporaceae 8 14 6.70 蜡蘑属 Laccaria 5 2.39
红菇科 Russulaceae 3 23 11.00 小皮伞属 Marasmius 6 2.87
小菇属 Mycena 11 5.26
光柄菇属 Pluteus 5 2.39
红菇属 Russula 17 8.13
栓菌属 Trametes 5 2.39
关闭全屏
  • BibTeX
  • EndNote
  • RefWorks
  • TxT
Links
Articles
Latest Articles
Most Read
Collections
Updates
Events
News
Multimedia
About
About Us
Contact
No. 86 Xueyuan South Road, Haidian District, Beijing
100081
010-62199257
qkjq@cast.org.cn

Copyright © 2025 China Association for Science and Technology. All rights reserved. For all open access content, the relevant licensing terms apply.
Sponsored by the Office of the Leading Group for Cybersecurity and Informatization of CAST, and supported by Science and Technology Review Publishing House